Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. Webster Andrews is active.

Publication


Featured researches published by C. Webster Andrews.


Nucleosides, Nucleotides & Nucleic Acids | 2000

Conformation and Local Environment of Nucleotides Bound To Hiv Type 1 Reverse Transcriptase (HIV-1 RT) in The Ground State

George R. Painter; C. Webster Andrews; Phillip A. Furman

Abstract Nuclear Overhauser effect experiments were used to characterize the protein environment and conformations of dTTP, dATP and AZTTP bound to HIV-RT in the ground state. The results show the initial binding sites for the nucleotides overlap but are not completely coincident. All of the bound nucleotides assume the same anti C4′-exo conformation.


Archive | 1991

A Thermodynamic Analysis of the Binding of Nucleic Acid to HIV-1 Reverse Transcriptase

George R. Painter; Lois L. Wright; C. Webster Andrews; Nancy Cheng; Sam Hopkins; Phillip A. Furman

Human immunodeficiency virus type 1 (HIV-1) encodes a Mg+2-dependent reverse transcriptase (E.C.2.7.7.49) that synthesizes a double-stranded DNA copy of genomic RNA. The enzyme purified from virions has been shown to consist of two polypeptides of molecular weights 66,000 and 51,000 (Hoffman et al., 1985; Di Marzo Veronese et al.,1986). The 66 kD subunit has both polymerase and RNase H activities. Like other retroviral reverse transcriptases, the associated RNase H activity is located on the carboxy terminal portion of the polypeptide (Johnson et al., 1986; Hansen et al., 1987; Tisdale et al., 1988). The 51 kD subunit is derived from the 66 kD polypeptide by cleavage at a protease sensitive site on the linker between the polymerase and RNase H domains (Lowe et al.,1988). Catalytically active HIV-1 reverse transcriptase has been cloned and expressed in E. coli (Larder et al., 1987). The recombinant, heterodimeric enzyme is kinetically indistinguishable from the native enzyme purified from virus.


Journal of Medicinal Chemistry | 2006

A Critical Assessment of Docking Programs and Scoring Functions

Gregory L. Warren; C. Webster Andrews; Anna-Maria Capelli; B Clarke; Judith M. LaLonde; Millard H. Lambert; Mika Lindvall; Neysa Nevins; Simon F. Semus; Stefan Senger; Giovanna Tedesco; Ian D. Wall; James Michael Woolven; Catherine E. Peishoff; Martha S. Head


Hepatology | 1998

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

Marchelle I. Allen; Manon Deslauriers; C. Webster Andrews; Graham Tipples; Kathie-Anne Walters; David L.J. Tyrrell; Nathaniel A. Brown; Lynn D. Condreay


Bioorganic & Medicinal Chemistry Letters | 2006

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385.

John F. Miller; C. Webster Andrews; Michael Stephen Brieger; Eric S. Furfine; Michael R. Hale; Mary H. Hanlon; Richard J. Hazen; Istvan Kaldor; Ed W. McLean; David J. Reynolds; Douglas Mccord Sammond; Andrew Spaltenstein; Roger D. Tung; Elizabeth M. Turner; Robert X. Xu; Ronald G. Sherrill


Journal of Medicinal Chemistry | 2001

2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.

Joseph H. Chan; Jean S. Hong; Robert Neil Hunter; G. Faye Orr; Jill R. Cowan; Douglas B. Sherman; Steven M. Sparks; Barbara E. Reitter; C. Webster Andrews; Richard J. Hazen; Marty St. Clair; Lawrence R. Boone; Rob G. Ferris; Katrina L. Creech; Grace B. Roberts; Steven A. Short; Kurt Weaver; Ronda J. Ott; Jingshan Ren; Andrew L. Hopkins; David I. Stuart; David K. Stammers


Journal of Heterocyclic Chemistry | 1996

The isolation and structure determination of cryptomisrine, a novel indolo[3,2-b]quinoline dimeric alkaloid from cryptolepis sanguinolenta†

Maged H. M. Sharaf; Paul L. Schiff; Albert N. Tackie; Charles H. Phoebe; Robert L. Johnson; Doug Minick; Ronald C. Crouch; Gary E. Martin; C. Webster Andrews


Magnetic Resonance in Chemistry | 1995

Submicromole structure elucidation: Cryptolepicarboline—a novel dimeric alkaloid from Cryptolepis sanguinolenta

Maged H. M. Sharaf; Paul L. Schiff; Albert N. Tackie; Charles H. Phoebe; Layne Howard; Carol Meyers; Chad E. Hadden; Susan K. Wrenn; Ann O. Davis; C. Webster Andrews; Doug Minick; Robert L. Johnson; John P. Shockcor; Ronald C. Crouch; Gary E. Martin


Journal of Heterocyclic Chemistry | 1995

15N CHEMICAL SHIFTS AND LONG-RANGE 1H-15N COUPLING PATHWAYS OF SELECTED STRYCHNOS ALKALOIDS

Gary E. Martin; Ronald C. Crouch; C. Webster Andrews


Journal of Heterocyclic Chemistry | 1995

Isolation and elucidation of the structure of homocryptolepinone

Maged H. M. Sharaf; Paul L. Schiff; Albert N. Tackie; Charles H. Phoebe; Ann O. Davis; C. Webster Andrews; Ronald C. Crouch; Gary E. Martin

Collaboration


Dive into the C. Webster Andrews's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul L. Schiff

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Albert N. Tackie

Centre for Scientific Research into Plant Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge